XML 26 R16.htm IDEA: XBRL DOCUMENT v3.25.3
Revenue
9 Months Ended
Sep. 30, 2025
Revenue from Contract with Customer [Abstract]  
Revenue
7.
Revenue

The following tables present the Company’s revenues disaggregated by revenue source:

 

 

Successor

 

 

 

Predecessor

 

 

Three Months Ended

 

 

 

Three Months Ended

 

 

September 30, 2025

 

 

 

September 28, 2024

 

Behavioral Subscription Revenues

$

145,152

 

 

 

$

172,194

 

Clinical Subscription Revenues

 

25,777

 

 

 

 

19,054

 

Subscription Revenues, net

$

170,929

 

 

 

$

191,248

 

Other Revenues, net

 

1,162

 

 

 

 

1,639

 

Revenues, net

$

172,091

 

 

 

$

192,887

 

 

 

Successor

 

 

 

Predecessor

 

 

Period from

 

 

 

Period from

 

 

 

 

 

June 25, 2025

 

 

 

December 29, 2024

 

 

Nine Months Ended

 

 

through September 30, 2025

 

 

 

through June 24, 2025

 

 

September 28, 2024

 

Behavioral Subscription Revenues

$

155,497

 

 

 

$

302,636

 

 

$

537,731

 

Clinical Subscription Revenues

 

27,510

 

 

 

 

58,317

 

 

 

57,529

 

Subscription Revenues, net

$

183,007

 

 

 

$

360,953

 

 

$

595,260

 

Other Revenues, net

 

1,251

 

 

 

 

2,615

 

 

 

6,248

 

Revenues, net

$

184,258

 

 

 

$

363,568

 

 

$

601,508

 

 

Information about Contract Balances

For Subscription Revenues, the Company can collect payment in advance of providing services. Any amounts collected in advance of services being provided are recorded in deferred revenue. In the case where amounts are not collected, but the service has been provided and the revenue has been recognized, the amounts are recorded in accounts receivable. The opening and ending balances of the Company’s deferred revenues were as follows:

 

 

 

Deferred Revenue

 

 

Deferred Revenue

 

 

 

Current

 

 

Long-Term

 

Balance at December 30, 2023 (Predecessor)

 

$

33,966

 

 

$

165

 

Net decrease during the period

 

 

(2,541

)

 

 

(110

)

Balance at September 28, 2024 (Predecessor)

 

$

31,425

 

 

$

55

 

 

 

 

Deferred Revenue

 

 

Deferred Revenue

 

 

 

Current

 

 

Long-Term

 

Balance at December 28, 2024 (Predecessor)

 

$

31,655

 

 

$

93

 

Net decrease during the period

 

 

(1,873

)

 

 

(8

)

Balance at June 24, 2025 (Predecessor)

 

$

29,782

 

 

$

85

 

 

 

Balance at June 25, 2025 (Successor)

 

$

29,782

 

 

$

85

 

Net decrease during the period

 

 

(2,151

)

 

 

(17

)

Balance at September 30, 2025 (Successor)

 

$

27,631

 

 

$

68

 

 

Revenue recognized from amounts included in current deferred revenue at December 30, 2023 (Predecessor) was $32,344 for the nine months ended September 28, 2024 (Predecessor). Revenue recognized from amounts included in current deferred revenue at December 28, 2024 (Predecessor) was $26,934 for the period from December 29, 2024 through June 24, 2025 (Predecessor) and $2,887 for the period from June 25, 2025 through September 30, 2025 (Successor). The Company’s long-term deferred revenue, which is included in other noncurrent liabilities on its unaudited consolidated balance sheets, represents revenue that will not be recognized during the next 12 months and is generally related to upfront payments received as an inducement for entering into certain sales-based royalty agreements with third-party licensees. This revenue is amortized on a straight-line basis over the term of the applicable agreement.